[
  {
    "question": "what is objective of taro",
    "answer": "The objective of TARO is to compare the safety and efficacy profiles of Taro Pharmaceuticals Inc.'s Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5% to Acanya (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%, and to demonstrate the superior efficacy of the two active formulations over that of the vehicle in the treatment of acne vulgaris. The study will assess the efficacy of the test product by evaluating IGA, lesion counting, and evaluation of application.",
    "date": "September 3, 2024 at 5:15:10 PM"
  },
  {
    "question": "what is objective of taro",
    "answer": "The objective of TARO is to compare the safety and efficacy profiles of Taro Pharmaceuticals Inc.'s Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5% to Acanya (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%, and to demonstrate the superior efficacy of the two active formulations over that of the vehicle in the treatment of acne vulgaris. The study will assess the efficacy of the test product by evaluating IGA, lesion counting, and evaluation of application.",
    "date": "September 3, 2024 at 5:15:10 PM"
  }
]